---
title: "BPSemi: The second-generation DrMos chip has currently been adopted by multiple customers and has entered the mass production stage"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/258820993.md"
description: "BPSemi's second-generation DrMos chip has been adopted by multiple customers and has entered the mass production stage. The company stated that the full range of products, including digital multi-phase controllers, DrMos, POL, and Efuse, has achieved scale sales, particularly in the new generation of graphics card applications, which have begun to ship in large quantities, driving overall business growth. Through continuous technological innovation, the performance of the second-generation DrMos chip has significantly improved, costs have decreased, and market competitiveness has been enhanced"
datetime: "2025-09-25T07:37:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/258820993.md)
  - [en](https://longbridge.com/en/news/258820993.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/258820993.md)
---

# BPSemi: The second-generation DrMos chip has currently been adopted by multiple customers and has entered the mass production stage

BPSemi stated during an institutional research that regarding the progress of the company's high-performance computing power chip business, the product line has currently achieved mass production and entered the scale sales stage for the full range of products including digital multi-phase controllers, DrMos, POL, and Efuse. In particular, applications for the new generation of graphics cards have begun large-scale shipments to several overseas and domestic customers, driving growth across the entire product line. Additionally, relying on the innovative breakthroughs of DrMos products to meet market demand, the overall business has experienced rapid growth, with more international and domestic customers achieving business breakthroughs. Through continuous BCD process innovation and product innovation, the performance of the second-generation DrMos chips has significantly improved, leading to cost reductions and further enhancing market competitiveness. Currently, multiple customers have adopted the products and entered the mass production stage

### Related Stocks

- [688368.CN](https://longbridge.com/en/quote/688368.CN.md)

## Related News & Research

- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [Mabwell Wins Wider China Indications for Denosumab Biosimilar as Global Push Accelerates](https://longbridge.com/en/news/287103520.md)
- [Baby food from Ireland recalled due to potential mould growth and spoilage: SFA](https://longbridge.com/en/news/287093082.md)
- [09:09 ETPacific Mind Health Releases Free Guide to Help People Start Conversations About Mental Health](https://longbridge.com/en/news/287072254.md)
- [Sayulita Wellness Retreat Launches Dedicated Ibogaine Treatment Platform to Champion Clinical Safety in Psychedelic Care](https://longbridge.com/en/news/287137533.md)